Auxly’s Q2 Beats Expectations !!! NET Revs of C$27.3 million showing sustained improvement of 21% over Q1-2022 and improvement of 31% over last year's Q2.
C$50 million NET revs for H1-2022
Gross profit margins improved to 36%
Increased Cash on Hand
Here's a qoute from Q2-2022 MD&A;
-----------
Net Revenues
For the three and six months ended June 30, 2022, net revenues were $27.3 million and $50.0 million as compared to $20.9 million and $30.0 million during the same period in 2021, an improvement of 31% and 66% respectively. Revenue in the second quarter of 2022 was comprised of approximately 40% in sales of dried flower and pre-roll Cannabis Products, with the remainder from oils and Cannabis 2.0 Product sales. Net revenues improved from the Company’s expansion of its Cannabis 1.0 Products and continued leadership in Cannabis 2.0 Products. Consistent with prior periods, as the Company does not participate in the Quebec market, approximately 85% of cannabis sales during the second quarter of 2022 originated from sales to British Columbia, Alberta and Ontario.
Gross Profit
Auxly realized a gross profit of $9.8 million and $13.5 million for the three and six months ending June 30, 2022 resulting in a 36% and 27% Gross Profit Margin2 respectively, as compared to $8.0 million (38%) and $10.3 million (34%) during the same periods in 2021. Cost of Finished Cannabis Inventory Sold Margin2 was 25%, 12% lower than the same period of 2021, however 2% greater than the first quarter of 2022.
------------
https://www.auxly.com/wp-content/themes/auxly2018/media/2022Q2/MDA_Q2-2022.pdf
.. and yet the SP still sees no love from the market.
WTF ?!?
The analysts got it wrong with their premature pre report negative BS!
Tell me, 'the MMs aren't royally and deliberately screwing Auxly over.' There's no other explanation for it.
This is BS!
Auxly issues a positive report that beats expectations and we see a drop in SP down to a C$62mil MC and a PB under 0.40 while other Mjs are trending positive.
Absolutely, Bloody Unbelievable !!
cheers